User:Chase me ladies, I'm the Cavalry/McVie

Professor Gordon McVie (born 13 January 1945) is a leading international authority in the research and treatment of cancer. Along with Umberto Veronesi he is the founding editor of ecancermedicalscience, an open access cancer journal from the European Institute of Oncology in Milan. He has authored almost 300 peer-reviewed articles and contributed to over 35 books. He currently serves on several committees of both the American Association for Cancer Research and the American Society of Clinical Oncology. He also serves on the boards of the National Cancer Institutes of France, Italy and Holland. In the UK, he was on the boards of cancer institutes in London, Glasgow and Manchester. He is currently Director of Cancer Intelligence, which provides advisory services to biotechnology and pharmaceutical companies, investors, the media and cancer patients as well as publishing ecancermedicalscience. He is a Senior Consultant to the European Institute of Oncology, and Visiting Professor at Glasgow University, in Scotland, and Honorary Consultant in Medical Oncology at the Welsh Cancer Institute, Cardiff.

His major contributions are the establishment of loco-regional routes of delivering chemotherapy e.g. intraperitoneal platinum in ovarian cancer, as effective treatment, the acceptance of chemotherapy for lung cancer throughout Europe, the shift from blood levels of drug as endpoints to tissue dynamics, either measured by PIXE, MRI or PET, the feasibility of chemoprevention trials in cancer practice, and the importance of ethnicity in patient management.

History
McVie obtained his PhDs in science and medicine at Edinburgh University, and was appointed Foundation Senior Lecturer at the Cancer Research Campaign Oncology Unit at the University of Glasgow. Under Gordon Hamilton-Fairley, he trained in the United States, spending sabbaticals in Paris, Sydney, Australia and Amsterdam.

During the 1980s, McVie spent time as a Consultant in Oncology at the Antoni van Leewenhoek hospital in Amsterdam. During his time there, he was also Clinical Research Director at the National Cancer Institute of the Netherlands. While there he co-founded the drug development office of the European Organisation for Treatment and Research into Cancer (EORTC). As President of EORTC, he set up the present Drug Development Group in Brussels, and with NCI support, the European New Drug Development Network. In the UK he was one of the architects of the Cancer Trials Networks in Scotland, Wales, and England, and was a founding member of the National Cancer Research Institute.

Previously Professor McVie was Chief Executive of the Cancer Research Campaign (CRC), the largest grant giving charity in the UK, which, under his aegis, took over sixty molecules from the laboratory into clinical trial.